Kydes Pharmaceuticals Overview

  • Founded

  • 2008

Founded
  • Status

  • Private

  • Latest Deal Type

  • 2ndary - Private

Kydes Pharmaceuticals General Information

Description

Producer of pharmaceutical products intended to reduce manufacturing unit cost. The company's products are used to treat therapeutic diseases, enabling clinicians to provide treatment for pain management focusing on oncology-oriented diseases.

Contact Information

Website
www.kydespharm.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • University of Maryland Baltimore County Research & Technology Park
  • 1450 South Rolling Road
  • Halethorpe, MD 21227
  • United States
+1 (410) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kydes Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Sep-2021 00000 Completed Generating Revenue
4. Early Stage VC 01-Sep-2012 0000 00000 Completed Generating Revenue
3. Grant 20-Aug-2010 00000 00000 Completed Generating Revenue
2. Accelerator/Incubator 12-Aug-2010 $300K $300K Completed Generating Revenue
1. Accelerator/Incubator 07-Jan-2009 Completed Generating Revenue
To view Kydes Pharmaceuticals’s complete valuation and funding history, request access »

Kydes Pharmaceuticals Patents

  • 10

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Kydes Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170296532-A1 Compositions for control of drug abuse Abandoned 03-May-2012 0000000000
US-20130295170-A1 Compositions for control of drug abuse Abandoned 03-May-2012 0000000000 0
CA-2750219-A1 Transdermal delivery of diclofenac, carbamazepine and benzydamine Granted 30-Jan-2009 00000000
CA-2750219-C Transdermal delivery of diclofenac, carbamazepine and benzydamine Active 30-Jan-2009 00000000
US-20110294763-A1 Transdermal delivery of dicolfenac, carbamazepine and benzydamine Abandoned 30-Jan-2009 A61K31/55 0
To view Kydes Pharmaceuticals’s complete patent history, request access »

Kydes Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Stephen Dordunoo Ph.D Founder, Chief Executive Officer, President & Chief Strategy Officer
To view Kydes Pharmaceuticals’s complete executive team members history, request access »

Ready to get started?

Request a free trial